The financial options and tools available today can be staggering. Many people are either overwhelmed or overworked by the choices they face. That’s clear from both the feedback I receive from people and studies I read. When people are overwhelmed and uncertain, they procrastinate. We need to prevent procrastination in financial matters. It’s too expensive.
One of my goals is to simplify your financial life. One reason is that simplification reduces procrastination. I also don’t want you to have to work full-time on your finances. The point of financial security is to be able to spend time doing the things you really enjoy. It’s a means to an end, not an end in itself. That’s why I constantly am searching for ways to simplify financial matters, and the best ways to do that are to consolidate and automate as much of your financial affairs as feasible.
You start by having as few financial service providers as you can. The simplest structure is to have a discount broker where you keep all your investment accounts (taxable accounts and IRAs), checking account, and safety funds. Many brokers now have an affiliated bank so the accounts are managed seamlessly and even issue credit and debit cards.
10 Best Mid Cap Stocks To Own For 2015: Powershares DB Commodity Index Tracking Fund (DBC)
PowerShares DB Commodity Index Tracking Fund (the Fund) and its subsidiary, DB Commodity Index Tracking Master Fund (the Master Fund), were formed as trusts. The Fund is designed to replicate positions in a commodity index.
The PowerShares DB Commodity Index Tracking Fund is based on the Deutsche Bank Liquid Commodity Index - Optimum Yield Excess Return (Index). The Fund is managed by DB Commodity Services LLC.
Advisors' Opinion:- [By Richard Stavros]
Another futures-based ETF is PowerShares Deutsche Bank Commodity Index (DBC). It is more diversified than DBA. It holds futures contracts in corn and wheat. But it also holds significant positions in gold, heating oil, and crude.
Top 10 Managed Healthcare Stocks For 2014: OGE Energy Corporation(OGE)
OGE Energy Corp., together with its subsidiaries, operates as an energy and energy services provider that offers physical delivery and related services for electricity and natural gas primarily in the south central United States. The company is involved in the generation, transmission, distribution, and sale of electric energy in Oklahoma and western Arkansas; and gathering, processing, transporting, storing, and marketing of natural gas. It furnishes retail electric service in 268 communities and their contiguous rural and suburban areas. OGE Energy Corp. operates coal-fired and natural gas-fired units, as well as wind-powered units. As of December 31, 2011, the company owned and operated 12 generating stations with an aggregate capability of 6,790 megawatts; and a transmission system comprising 51 substations and 4,258 structure miles of lines in Oklahoma, and 7 substations and 279 structure miles of lines in Arkansas. Its distribution system consisted of 353 substations , 27,854 structure miles of overhead lines, 1,895 miles of underground conduit, and 10,120 miles of underground conductors in Oklahoma, as well as 37 substations, 2,250 structure miles of overhead lines, 212 miles of underground conduit, and 572 miles of underground conductors in Arkansas. The company also owned approximately 6,019 miles of intrastate natural gas gathering pipelines in Oklahoma and Texas; approximately 2,250 miles of intrastate natural gas transportation pipelines in Oklahoma; and 2 underground natural gas storage facilities and 8 operating natural gas processing plants in Oklahoma. It serves residential, commercial, industrial, oilfield, public authorities, and street light operators. OGE Energy Corp. was founded in 1995 and is based in Oklahoma City, Oklahoma.
Advisors' Opinion:- [By Chuck Carnevale]
OGE Energy Corp. (OGE): Another Utility with Slightly Higher Growth
Our second example, OGE Energy Corp., differs from our first only by virtue of the fact that its earnings growth rate since 1998 has averaged over 5% per annum. Nevertheless, we once again discover that the PE ratio of 15 represents a strong proxy for this company�� valuation. During the short time intervals when price deviates from fair value PE of 15, it doesn�� take long for price to move back into alignment with earnings.
- [By Robert Rapier]
Last month in Play Ball: More IPOs on Deck, I mentioned that the next master limited partnership to IPO could be Enable Midstream Partners (NYSE: ENBL). Enable Midstream was formed in May 2013 as a joint venture by affiliates of CenterPoint Energy (NYSE: CNP), OGE Energy (NYSE: OGE) and ArcLight Capital Partners.
- [By GURUFOCUS]
OGE Energy Corp. (OGE) operates as an energy and energy services provider that offers physical delivery and related services for electricity and natural gas primarily in the south central U.S. Dec. 4, the company increased its quarterly dividend 7.8% to $0.225 per share. The dividend is payable Jan. 30, 2014, to shareowners of record Jan. 10, 2014. The yield based on the new payout is 2.7%.
- [By Robert Rapier]
Enable Midstream Partners�(NYSE: ENBL), a joint venture by affiliates of�CenterPoint Energy�(NYSE: CNP),�OGE Energy�(NYSE: OGE) and ArcLight Capital Partners. Enable Midstream Partners is one of the largest midstream partnerships in the US, with oil and gas midstream assets that extend from western Oklahoma and the Texas Panhandle to Alabama and from Louisiana to Illinois
Top 10 Managed Healthcare Stocks For 2014: Elan Corporation PLC (ELN)
Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan�� business focuses on neurodegenerative diseases, such as Alzheimer�� disease and Parkinson�� disease; autoimmune diseases, including MS and Crohn�� disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn�� disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.
Tysabri
Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.
In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics��(SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company�� research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.
Beta Amyloid Immunotherapies (AIP)
Beta amyloid immunotherapy includes the treatment of Alzheimer�� disease by inducing or enhancing the body�� immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized monoclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer�� disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).
ELND005, an A� Aggregation Inhibitor
The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.
Neotope Biosciences Limited
Neotope Biosciences Limited (Neotope) is the Company�� wholly owned subsidiary that focuses on the discovery and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope�� portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson�� disease, tau for Alzheimer�� disease and other tauopathies. It also has a program for type 2-diabetes.
Onclave Therapeutics Limited
Elan�� wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave�� program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave�� pipeline includes additional compounds with relevance in diverse cancer indications.
The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.
Advisors' Opinion:- [By Brian Orelli]
Most recently Elan (NYSE: ELN ) spun out its drug discovery business into Prothena. Without the burden of a drug discovery unit, the parent company is now being pursued by Royalty Pharma, although Elan isn't keen on its current offer.
- [By Tim Brugger]
After confirming an unsolicited takeover bid from privately held investment firm Royalty Pharma in late February, Ireland-based Elan (NYSE: ELN ) announced today that its board has unanimously rejected the offer.
- [By Sean Williams]
Elan (NYSE: ELN )
Having a lot of cash in the biotech sector doesn't mean that a company's clinical trials will translate into success. Elan's claim to fame was the development of multiple sclerosis drug Tysabri, which it licensed out to Biogen Idec (NASDAQ: BIIB ) . Sales of the drug hit $1.6 billion last year.
Top 10 Managed Healthcare Stocks For 2014: Huntington Bancshares Incorporated(HBAN)
Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services. The company?s Retail and Business Banking segment offers various financial products and services, including checking, savings, and money market accounts, certificates of deposit, consumer loans, and small business loans and leases; and investments, insurance, interest rate risk protection, foreign exchange hedging, and treasury management services to consumer and small business customers. Its Regional and Commercial Banking segment provides commercial lending; depository and liquidity management products; treasury management solutions; equipment and technology leasing; international services; and capital markets services, such as interest rate risk protection, foreign exchange hedging and sales, trading of securities, mezzanine investment capabilities, and employee benefit programs to government, not-f or-profit, health-care, and publicly traded entities. The company?s Automobile Finance and Commercial Real Estate segment offers financing for the purchase of automobiles, and new and used vehicle inventory by automotive dealerships; and financing for land, buildings, and other commercial real estate owned or constructed by real estate developers, automobile dealerships, or other customers. Its Wealth Advisors, Government Finance, and Home Lending segment provides investment management; investment servicing; custody, and corporate trust and retirement plan services; and administrative and operational support to fund to high net worth customers. It also offers online, mobile, and telephone banking services; and operates approximately 1,300 automated teller machines. As of December 31, 2011, the company had 652 branches located in Ohio, Michigan, Pennsylvania, Indiana, West Virginia, and Kentucky. Huntington Bancshares Incorporated was founded in 1866 and is headquartered in Columbus, Ohio.
Advisors' Opinion:- [By David Hanson and Matt Koppenheffer]
In this segment of The Motley Fool's everything-financials show,�Where the Money Is, banking analysts Matt Koppenheffer and David Hanson tell investors what they will be watching when PNC Financial Services (NYSE: PNC ) , Huntington Bancshares (NASDAQ: HBAN ) , and KeyCorp� (NYSE: KEY ) �report earnings this week
- [By Lauren Pollock]
Huntington Bancshares Inc.'s(HBAN) fourth-quarter earnings fell 5.7% as the lender’s revenue declined, though it wrote off fewer bad loans and its loan portfolio grew. Shares edged down 1.9% to $9.71 premarket.
- [By Jay Jenkins]
Free checking? A 24-hour grace period on overdraft fees? Products actually designed to help the consumer better manage their finances? It seems like this sort of customer-centric banking would only exist in a dream world, but at Huntington Bancshares (NASDAQ: HBAN ) , it's reality.
- [By Amanda Alix]
Mortgages down, but commercial loans are up
Like its peer Huntington Bancshares� (NASDAQ: HBAN ) , New York Community saw a slowdown in residential mortgage refinancing�activity due to higher interest rates. But, like Huntington and KeyCorp (NYSE: KEY ) , the bank was able to improve in other areas. New York Community enjoyed higher mortgage servicing income�in the second quarter, for example -- an area in which KeyCorp is also expanding, having recently acquired $110 billion in commercial loan servicing rights�from Bank of America (NYSE: BAC ) earlier this year.
Top 10 Managed Healthcare Stocks For 2014: Naturalnano Inc (NNAN)
NaturalNano, Inc. (NaturalNano), incorporated on February 18, 2000, is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house. During the year ended December 31, 2011,the Company�� activities are directed toward research, development, production and marketing of its technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for cosmetics, health and beauty products, and polymers, plastics and composites.
The company�� halloysite natural tube (HNT) products involve filling HNTs with active agents for use in the polymer composites, health and beauty, household product, and agrichemical industries. The filled tube product contains a material of interest within the tubes, such as an antimicrobial compound to provide antimicrobial properties to the resulting polymer composite material. The filled-tube products will focus on the utilization of the tubular nature of the halloysite nanotubes, by filling or adsorbing the tubes with active agents for the polymer nanocomposites, household products, cosmetics, agriculture, and pharmaceutical industries. The Company designs, manufactures and sells custom designed error prevention/safety checklist boards.
The Company competes with Air Products and Chemicals, BASF, Dow, E.I. DuPont de Nemours & Company, Applied Minerals, Davis International and Imagexpress.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Naturalnano Inc (OTCMKTS: NNAN), Global Payout, Inc (OTCMKTS: GOHE) and Blue Water Global Group Inc (OTCBB: BLUU) were either jumping higher or diving lower yesterday. To complicate matters for investors, two of these small cap stocks have been subjects of disclosures about paid promotion or investor relation campaigns. So what will these three small caps do for the rest of this week? Here is a closer look to help you decide on a trading or investing strategy:
Top 10 Managed Healthcare Stocks For 2014: Spdr S&P Pharmaceuticals Etf (XPH)
SPDR S&P Pharmaceuticals Exchange Traded Fund (The Fund) seeks to replicate as closely as possible, before expenses, the performance of an index derived from the pharmaceuticals segment of a United States total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Pharmaceuticals Select Industry Index (the Pharmaceuticals Index).
The Pharmaceuticals Index represents the pharmaceuticals sub-industry portion of the S&P TMI. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange (NYSE), American Stock Exchange (AMEX), National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some pharmaceutical stocks to your portfolio, the SPDR S&P Pharmaceuticals ETF (NYSEMKT: XPH ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The SPDR ETF's expense ratio -- its annual fee -- is a relatively low 0.35%.
This ETF has trounced the world markets over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.
Top 10 Managed Healthcare Stocks For 2014: Whitestone REIT (WSR)
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in the metropolitan areas. The Company is internally managed and owns a real estate portfolio of 36 properties containing approximately three million square feet of leasable space, located in Texas, Arizona and Illinois. As of December 31, 2009, the Company had one property, which accounted for more than 10% of the total gross revenue and leasing of the properties. In December 2011, the Company announced that it had closed on the purchase of Phase I of Pinnacle of Scottsdale, a 113,108 square foot 100% leased Class A Community Center in North Scottsdale. In December 2011, it purchased shops at Starwood. In August 2012, the Company closed on the purchase of Paradise Plaza, a 125,898 square foot 100%-leased Community Center in Paradise Valley. In September 2012, the Company purchased Village Square at Dana Park, a 310,979 square foot Community Center located in the Mesa submarket of Phoenix, plus six developed pads (total of 2.9 acres) and the adjacent 4.7 acre parcel of development land to add another 200,000 square feet of leasable space. In December 2012, the Company closed on the off-market purchase of The Shops at Pecos Ranch. In April 2013, it closed on the off-market purchase of Headquarters Village, a 89,134 square foot (sf) Community Center located within the Preston Road retail corridor in Plano, Texas. Effective July 1, 2013, Whitestone REIT acquired Anthem Marketplace. In October 2013, Whitestone REIT completed the purchase of Fountain Hills Plaza, retail center in Fountain Hills, Arizona. In December 2013, Whitestone REIT purchased Market Street at DC Ranch in Scottsdale.
As of December 31, 2009, the Company owned a 64.7% interest in Whitestone REIT Operating Partnership, L.P. (the Operating Partnership). As of December 31, 2009, the Company owned a real estate portfolio consisting of 36 properties located in three states. As of December 3! 1, 2009, the occupancy rate at the operating properties was 82% based on leasable square footage.
Advisors' Opinion:- [By Reuben Brewer]
And, sometimes, being small is actually a good thing. Take, for example, Whitestone REIT (NYSE: WSR ) . This company operates a portfolio of roughly 60 properties in Texas, Arizona, and Illinois. That said, it only has one property in Illinois, so it's really focused around just two markets.
- [By Charles Sizemore]
Returning to U.S. shores, the next of our monthly dividend stocks is Whitestone REIT (WSR), a smaller REIT that specializes in shopping centers.
I should start by making one point very clear: while I like Whitestone, it is a very different kind of REIT than Realty Income or American Realty Capital Properties. Its property portfolio is far less geographically diversified (with properties in just three states), and it is a much smaller company by market cap ($290 million).
No comments:
Post a Comment